Mycophenolate mofetil in IBD patients.
| Publicado en: | Lancet Vol. 354; no. 9187; pp. 1386 - 1388 |
|---|---|
| Autores principales: | , , |
| Formato: | commentary Journal Article |
| Publicado: |
Lancet
10/16/99
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=119723999&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 119723999 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 10/16/99 vid: 354 iid: 9187 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 119723999 119723999 20264694 NLM10533889 119723999 10.1016/s0140-6736(05)76240-1 NLM10533889 119723999 ppf: 1386 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Mycophenolate mofetil in IBD patients. aug: au: Radford-Smith, G L Taylor, P Florin, T H sug: subj: Inflammatory Bowel Diseases Drug Therapy Mycophenolic Acid Immunosuppressive Agents Therapeutic Use Mycophenolic Acid Adverse Effects Female Immunosuppressive Agents Adverse Effects Mycophenolic Acid Therapeutic Use Male Female Male pubtype: Academic Journal doctype: commentary Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|